Literature DB >> 26902899

High-throughput allogeneic antibody detection using protein microarrays.

Jed Paul1, Bita Sahaf2, Spenser Perloff3, Kelsi Schoenrock4, Fang Wu5, Hideki Nakasone6, John Coller7, David Miklos8.   

Abstract

Enzyme-linked immunosorbent assays (ELISAs) have traditionally been used to detect alloantibodies in patient plasma samples post hematopoietic cell transplantation (HCT); however, protein microarrays have the potential to be multiplexed, more sensitive, and higher throughput than ELISAs. Here, we describe the development of a novel and sensitive microarray method for detection of allogeneic antibodies against minor histocompatibility antigens encoded on the Y chromosome, called HY antigens. Six microarray surfaces were tested for their ability to bind recombinant protein and peptide HY antigens. Significant allogeneic immune responses were determined in male patients with female donors by considering normal male donor responses as baseline. HY microarray results were also compared with our previous ELISA results. Our overall goal was to maximize antibody detection for both recombinant protein and peptide epitopes. For detection of HY antigens, the Epoxy (Schott) protein microarray surface was both most sensitive and reliable and has become the standard surface in our microarray platform.
Copyright © 2016. Published by Elsevier B.V.

Entities:  

Keywords:  Alloantibody; Chronic graft versus host disease; HY antigen; Hematopoietic cell transplantation; Protein microarray

Mesh:

Substances:

Year:  2016        PMID: 26902899      PMCID: PMC5495102          DOI: 10.1016/j.jim.2016.02.009

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  15 in total

1.  Systematic comparison of surface coatings for protein microarrays.

Authors:  Birgit Guilleaume; Andreas Buness; Christian Schmidt; Fritz Klimek; Gerhard Moldenhauer; Wolfgang Huber; Dorit Arlt; Ulrike Korf; Stefan Wiemann; Annemarie Poustka
Journal:  Proteomics       Date:  2005-12       Impact factor: 3.984

2.  Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission.

Authors:  David B Miklos; Haesook T Kim; Katherine H Miller; Luxuan Guo; Emmanuel Zorn; Stephanie J Lee; Ephraim P Hochberg; Catherine J Wu; Edwin P Alyea; Corey Cutler; Vincent Ho; Robert J Soiffer; Joseph H Antin; Jerome Ritz
Journal:  Blood       Date:  2004-12-21       Impact factor: 22.113

3.  Recombinant antigen microarrays for serum/plasma antibody detection.

Authors:  Persis P Wadia; Bita Sahaf; David B Miklos
Journal:  Methods Mol Biol       Date:  2011

4.  H-Y antigen-binding B cells develop in male recipients of female hematopoietic cells and associate with chronic graft vs. host disease.

Authors:  Bita Sahaf; Yang Yang; Sally Arai; Leonard A Herzenberg; Leonore A Herzenberg; David B Miklos
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

5.  Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors.

Authors:  David B Miklos; Haesook T Kim; Emmanuel Zorn; Ephraim P Hochberg; Luxuan Guo; Alex Mattes-Ritz; Sebastien Viatte; Robert J Soiffer; Joseph H Antin; Jerome Ritz
Journal:  Blood       Date:  2003-09-25       Impact factor: 22.113

6.  Allogeneic HY antibodies detected 3 months after female-to-male HCT predict chronic GVHD and nonrelapse mortality in humans.

Authors:  Hideki Nakasone; Lu Tian; Bita Sahaf; Takakazu Kawase; Kelsi Schoenrock; Spenser Perloff; Christine E Ryan; Jed Paul; Rakesh Popli; Fang Wu; Joanne M Otani; John Coller; Edus H Warren; David B Miklos
Journal:  Blood       Date:  2015-03-12       Impact factor: 22.113

7.  Antibodies specifically target AML antigen NuSAP1 after allogeneic bone marrow transplantation.

Authors:  Persis P Wadia; Marc Coram; Randall J Armstrong; Michael Mindrinos; Atul J Butte; David B Miklos
Journal:  Blood       Date:  2010-01-06       Impact factor: 22.113

8.  Risks and benefits of sex-mismatched hematopoietic cell transplantation differ according to conditioning strategy.

Authors:  Hideki Nakasone; Mats Remberger; Lu Tian; Petter Brodin; Bita Sahaf; Fang Wu; Jonas Mattsson; Robert Lowsky; Robert Negrin; David B Miklos; Everett Meyer
Journal:  Haematologica       Date:  2015-08-06       Impact factor: 9.941

9.  Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants.

Authors:  Sophia S B Randolph; Theodore A Gooley; Edus H Warren; Frederick R Appelbaum; Stanley R Riddell
Journal:  Blood       Date:  2003-09-11       Impact factor: 22.113

Review 10.  Protein microarrays: high-throughput tools for proteomics.

Authors:  Oda Stoevesandt; Michael J Taussig; Mingyue He
Journal:  Expert Rev Proteomics       Date:  2009-04       Impact factor: 3.940

View more
  1 in total

1.  A confirmation of chronic graft-versus-host disease prediction using allogeneic HY antibodies following sex-mismatched hematopoietic cell transplantation.

Authors:  Jed Paul; Hideki Nakasone; Bita Sahaf; Fang Wu; Kathy Wang; Vincent Ho; Juan Wu; Haesook Kim; Bruce Blazar; Jerome Ritz; Alan Howard; Corey Cutler; David Miklos
Journal:  Haematologica       Date:  2019-01-17       Impact factor: 9.941

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.